Annemarie Woodland

AnneMarie Woodland is a seasoned regulatory affairs and quality assurance executive with extensive experience in the biotechnology industry. Currently serving as Senior Vice President of Regulatory Affairs and Quality at Beam Therapeutics since February 2022, AnneMarie has a proven track record of successfully guiding the development and regulatory strategies for biologics, particularly in gene and cell therapy. Previous roles include senior leadership positions at companies such as Replimune, uniQure, Amgen, and BioVex, where AnneMarie demonstrated expertise in global registration strategies, regulatory compliance, and the establishment of departments designed to meet regulatory requirements. AnneMarie holds a Master's degree in Management from Lesley University and a Bachelor's degree in Medical Technology from Fitchburg State University.